<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="215">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on March 04, 2022</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04819074</url>
  </required_header>
  <id_info>
    <org_study_id>PRAEMIUM</org_study_id>
    <nct_id>NCT04819074</nct_id>
  </id_info>
  <brief_title>Prediction of Outcomes After Surgery for Unruptured Intracranial Aneurysms</brief_title>
  <acronym>PRAEMIUM</acronym>
  <official_title>The Prediction of Adverse Events After Microsurgery for Intracranial Unruptured Aneurysms (PRAEMIUM) Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Zurich</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Macquarie University, Australia</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Melbourne</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Kepler University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Medical University Innsbruck</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>General University Hospital, Prague</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Universitätsklinikum Köln</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University Hospital, Frankfurt</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University Medical Center Mainz</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Göttingen</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University Hospital Dresden</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Charite University, Berlin, Germany</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Heinrich-Heine University, Duesseldorf</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Roma La Sapienza</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Padova</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Florence</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Messina</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Universita di Verona</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Uniuversity of Genua, Italy</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Leiden University Medical Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>UMC Utrecht</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Burdenko Neurosurgery Institute</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Sahlgrenska University Hospital, Sweden</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Bern</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Barrow Neurological Institute</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Stanford University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Emory University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Wisconsin, Madison</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of California, San Francisco</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Illinois at Chicago</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Brigham and Women's Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Mayo Clinic</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of California, Los Angeles</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>NorthShore University HealthSystem</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Fondazione Policlinico Universitario Agostino Gemelli IRCCS</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Zurich</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Accurate preoperative identification of patients at high risk for adverse outcomes would be&#xD;
      clinically advantageous, as it would allow enhanced resource preparation, better surgical&#xD;
      decision-making, enhanced patient education and informed consent, and potentially even&#xD;
      modification of certain modifiable risk factors. The aim of the Prediction of adverse events&#xD;
      after microsurgery for intracranial unruptured aneurysms (PRAEMIUM) study is therefore to&#xD;
      develop and externally validate a clinically applicable, robust ML-based prediction tool&#xD;
      based on multicenter data from a range of international centers.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Introduction Unruptured intracranial aneurysms (UIAs) are incidentally detected at an&#xD;
      increasing rate, mostly owing to the rise in availability of non-invasive cranial imaging.&#xD;
      Decision-making in UIAs is complex and requires consideration of many risk factors for&#xD;
      aneurysm growth and rupture to balance the benefits and risks of treatment versus&#xD;
      observation. This is due to: 1) the high morbidity and case fatality inherent to aneurysmal&#xD;
      subarachnoid hemorrhage (SAH) 2) the relatively low rupture rate of unruptured aneurysms; 3)&#xD;
      the potential morbidity and mortality rate associated with either microsurgical or&#xD;
      endovascular treatment.&#xD;
&#xD;
      Some consistent risk factors for rupture have been identified, including involvement of the&#xD;
      posterior circulation, larger diameter, higher age, and some specific populations such as&#xD;
      Japanese and Finnish patients. Many other risk factors have been suggested based on varying&#xD;
      levels of evidence. However, it is difficult to integrate this considerable number of factors&#xD;
      into a single risk assessment and to present a clear clinical decision making algorithm to&#xD;
      patients. A range of scoring systems have been developed and validated to approximate the&#xD;
      risk of rupture (PHASES) and growth (ELAPSS) or to balance the risks and benefits of&#xD;
      microsurgical treatment versus follow-up imaging directly (UIATS) by integrating some of&#xD;
      these risk factors. Still, these scores are focused on predicting rupture events instead of&#xD;
      neurological outcome. In addition, they usually are focused on solely one outcome, instead of&#xD;
      providing a wide range of objective predictive analytics that may then improve shared&#xD;
      decision-making.&#xD;
&#xD;
      Machine learning (ML) methods have been extraordinarily effective at integrating many&#xD;
      clinical patient variables into one holistic risk prediction tailored to each patient. A&#xD;
      previous pilot study has been carried out to assess the feasibility of predicting surgical&#xD;
      outcomes after surgery for UIAs in a small single-center sample, and it was found that&#xD;
      prediction was feasible with good performance metrics, and the most important factors to be&#xD;
      included in such models were also identified. A robust, multicenter, externally validated&#xD;
      prediction model or predictive score for surgical outcome after microsurgery for UIAs does&#xD;
      not yet exist.&#xD;
&#xD;
      Methods Data will be collected by a range of international centers. Overall, the model will&#xD;
      be built and publication will be compiled according to the transparent reporting of a&#xD;
      multivariable prediction model for individual prognosis or diagnosis (TRIPOD) guidelines.&#xD;
&#xD;
      Each center will collect their data either retrospectively, or from a prospective registry,&#xD;
      or from a prospective registry supplemented by retrospectively collected variables. Data from&#xD;
      patients operated from January 1st 2010 and onwards will be eligible for inclusion. Data&#xD;
      collection should be completed, and deidentified data should be sent to the sponsor&#xD;
      institution.&#xD;
&#xD;
      A standardized Excel spreadsheet will be provided by the sponsor. The data will be entered in&#xD;
      standardized and anonymized form. This spreadsheet will only contain a study-specific patient&#xD;
      number. The data set is anonymized source data that includes clinical data extracted from&#xD;
      electronic health records (retrospectively or from a prospective registry of already existing&#xD;
      data). The data will be anonymized upon entering them into the PRAEMIUM Excel spreadsheet,&#xD;
      after which the patients will be numbered consecutively and there will be no way to trace the&#xD;
      data back to individual patients. No identifiable data such as date of birth will be&#xD;
      included. Whenever the PRAEMIUM Excel spreadsheet is transferred, it will be encrypted using&#xD;
      a password and sent through a secure institutional e-mail server. The password will be sent&#xD;
      in a separate e-mail. Some missing data is acceptable, but should be kept to a minimum (i.e.&#xD;
      must be &lt; 10%)&#xD;
&#xD;
      Endpoint Definitions Models will be developed for the following three endpoints at discharge:&#xD;
      Poor neurological outcome (1), as well as presence of (2) new sensorimotor neurological&#xD;
      deficits and (3) any complications (surgical or non-surgical). Neurological outcome was&#xD;
      assessed by the modified Rankin scale (mRS), and a favorable neurological outcome was defined&#xD;
      as mRS 0, 1, or 2. Complications will be assessed using the modified 2009 Clavien-Dindo&#xD;
      grading (CDG), and occurrence of a complication was defined as any deviation from CDG 0.The&#xD;
      Clavien-Dindo grading system is a classification of surgical complications: Grad 0 signifying&#xD;
      no complication, Grade I identifying complications with any deviation from the normal intra-&#xD;
      or postoperative course requiring medical treatment, and so forth. Detailed definitions are&#xD;
      provided in the Excel spreadsheet. Surgery-related as well as none-surgery-related&#xD;
      complications are counted. In case of multiple complications, only the complication with the&#xD;
      highest CDG was counted per patient.&#xD;
&#xD;
      Input Feature Definitions All features are measured preoperatively. Recorded baseline&#xD;
      variables will include age, gender, maximum aneurysm diameter, anatomical location (artery),&#xD;
      total number of aneurysms per patient, if multiple aneurysms were treated during the index&#xD;
      session, calcification of the aneurysm wall or neck, aneurysm morphology (saccular,&#xD;
      dissecting, fusiform, or other), involvement of critical perforating or branch vessels, and&#xD;
      intraluminal thrombosis.&#xD;
&#xD;
      In addition, the investigators will capture prior SAH, mRS at admission, prior aneurysm&#xD;
      treatment, presence of anticoagulation/antiplatelet therapy preoperatively, and hypertension,&#xD;
      as well as American Society of Anesthesiologists (ASA) grading, the PHASES, ELAPSS, and UIATS&#xD;
      scores including the UIATS &quot;pro-repair&quot; and &quot;pro-conservative treatment&quot; subscores. The&#xD;
      unruptured intracranial aneurysm treatment score (UIATS) consists of two subscores: One that&#xD;
      represents the strength of recommendation for invasive repair of an unruptured aneurysm, and&#xD;
      one that represents the strength of recommendation for conservative management of an&#xD;
      unruptured aneurysm. The final overall UIATS score is subsequently calculated as the&#xD;
      difference between the two subscores. Also included was the surgical approach: minimally&#xD;
      invasive or standard approach, and whether a bypass was performed.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 20, 2021</start_date>
  <completion_date type="Anticipated">October 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">January 1, 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>modified Rankin Scale</measure>
    <time_frame>Within 24 hours of admission to discharge, assessed up to 30 days</time_frame>
    <description>Neurological outcome was assessed by the modified Rankin scale (mRS), and a favorable neurological outcome was defined as mRS 0, 1, or 2. The scale runs from 0 to 5, and higher scores mean a worse outcome.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Sensorimotor neurological deficits</measure>
    <time_frame>Within 24 hours of admission to discharge, assessed up to 30 days</time_frame>
    <description>Any new sensorimotor neurological deficits after surgery will be captured.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Clavien Dindo Complication Grading</measure>
    <time_frame>Within 24 hours of admission to discharge, assessed up to 30 days</time_frame>
    <description>Complications will be assessed using the modified 2009 Clavien-Dindo grading (CDG), and occurrence of a complication was defined as any deviation from CDG 0. The CDG runs from 0 to 5, and higher scores mean a worse complication.</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">4000</enrollment>
  <condition>Aneurysm, Brain</condition>
  <arm_group>
    <arm_group_label>Patients with unruptured brain aneurysms</arm_group_label>
    <description>We will include all adult patients (18 years or older) undergoing microsurgical treatment for UIAs. No specific exclusion criteria will be set. Patients with prior SAH may only be included when surgical treatment occurred at least 4 weeks after ictus. Only patients treated from January 1st 2010 onwards can be included in this study.&#xD;
No intervention.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Microsurgery</intervention_name>
    <description>Microsurgery for unruptured intracranial aneurysm</description>
    <arm_group_label>Patients with unruptured brain aneurysms</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        We will include all adult patients (18 years or older) undergoing microsurgical treatment&#xD;
        for UIAs. No specific exclusion criteria will be set. Patients with prior SAH may only be&#xD;
        included when surgical treatment occurred at least 4 weeks after ictus. Only patients&#xD;
        treated from January 1st 2010 onwards can be included in this study.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Adult patients (18 or older)&#xD;
&#xD;
          -  Undergone microsurgical treatment for unruptured intracranial aneurysm&#xD;
&#xD;
          -  Patients with prior SAH may only be included when surgical treatment occurred at least&#xD;
             4 weeks after ictus.&#xD;
&#xD;
          -  Treated from January 1st 2010 onwards&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  No specific exclusion criteria&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Victor Staartjes</last_name>
    <role>Principal Investigator</role>
    <affiliation>USZ</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Giuseppe Esposito</last_name>
    <role>Principal Investigator</role>
    <affiliation>USZ</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Victor Staartjes</last_name>
    <phone>+41 44 255 2660</phone>
    <email>praemium@usz.ch</email>
  </overall_contact>
  <location>
    <facility>
      <name>Barrow Neurological Institute</name>
      <address>
        <city>Phoenix</city>
        <state>Arizona</state>
        <zip>85013</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Michael Lawton</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>UCLA</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90095</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Linda Liau</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>UCSF</name>
      <address>
        <city>San Francisco</city>
        <state>California</state>
        <zip>94143</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Mitchel S Berger</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Stanford University</name>
      <address>
        <city>Stanford</city>
        <state>California</state>
        <zip>94305</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Gary K Steinberg</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Emory University Hospital</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30322</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Daniel Barrow</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Illinois</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60612</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Fady Charbel</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Brigham and Women's Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02115</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Antonio Chiocca</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Mayo Clinic</name>
      <address>
        <city>Rochester</city>
        <state>Minnesota</state>
        <zip>55902</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Giuseppe Lanzino</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>North Shore University Hospital</name>
      <address>
        <city>Manhasset</city>
        <state>New York</state>
        <zip>11030</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Amir Dehdashti</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Wisconsin</name>
      <address>
        <city>Madison</city>
        <state>Wisconsin</state>
        <zip>53792</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Mustafa K Baskaya</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Royal Melbourne Hospital</name>
      <address>
        <city>Melbourne</city>
        <country>Australia</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Kate Drummond</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Macquarie University</name>
      <address>
        <city>Sydney</city>
        <country>Australia</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Antonio Di Ieva</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Innsbruck University</name>
      <address>
        <city>Innsbruck</city>
        <country>Austria</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Claudius Thomé</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Linz Kepler Klinikum</name>
      <address>
        <city>Linz</city>
        <country>Austria</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Andreas Gruber</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Prague University</name>
      <address>
        <city>Praha</city>
        <country>Czechia</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Vladimir Benes</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Charité Univesitätsmedizin</name>
      <address>
        <city>Berlin</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Peter Vajkoczy</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Dresden Uniklinikum</name>
      <address>
        <city>Dresden</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Gabriele Schackert</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Düsseldorf Universitätsmedizin</name>
      <address>
        <city>Düsseldorf</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Daniel Hänggi</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Frankfurt University</name>
      <address>
        <city>Frankfurt</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Volker Seifert</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Universitätsmedizin Göttingen</name>
      <address>
        <city>Göttingen</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Veit Rohde</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Cologne</name>
      <address>
        <city>Köln</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Roland Goldbrunner</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Unimedizin Mainz</name>
      <address>
        <city>Mainz</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Florian Ringel</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Florence - Careggi</name>
      <address>
        <city>Florence</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Alessandro Della Puppa</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Genoa</name>
      <address>
        <city>Genoa</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Gianluigi Zona</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Messina</name>
      <address>
        <city>Messina</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Antonino Germano</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Carlo Besta</name>
      <address>
        <city>Milan</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Paolo Ferroli</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Padova University</name>
      <address>
        <city>Padova</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Domenico D'Avella</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Gemelli University Hospital</name>
      <address>
        <city>Roma</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Alessandro Olivi</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Sapienza University</name>
      <address>
        <city>Roma</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Antonio Santoro</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Verona</name>
      <address>
        <city>Verona</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Giampietro Pinna</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Amsterdam UMC</name>
      <address>
        <city>Amsterdam</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>W. Peter Vandertop</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Leiden University</name>
      <address>
        <city>Leiden</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Wilco C Peul</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>UMC Utrecht</name>
      <address>
        <city>Utrecht</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Albert van der Zwan</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Burdenko Hospital</name>
      <address>
        <city>Moscow</city>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Eliava Shalva</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Sahlgrenska Hospital</name>
      <address>
        <city>Göteborg</city>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Asgeir Jakola</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Inselspital Bern</name>
      <address>
        <city>Bern</city>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Andreas Raabe</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>University Hospital Zurich</name>
      <address>
        <city>Zürich</city>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Victor Staartjes</last_name>
    </contact>
    <contact_backup>
      <last_name>Giuseppe Esposito</last_name>
    </contact_backup>
  </location>
  <location_countries>
    <country>Australia</country>
    <country>Austria</country>
    <country>Czechia</country>
    <country>Germany</country>
    <country>Italy</country>
    <country>Netherlands</country>
    <country>Russian Federation</country>
    <country>Sweden</country>
    <country>Switzerland</country>
    <country>United States</country>
  </location_countries>
  <verification_date>December 2021</verification_date>
  <study_first_submitted>March 18, 2021</study_first_submitted>
  <study_first_submitted_qc>March 25, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">March 26, 2021</study_first_posted>
  <last_update_submitted>December 5, 2021</last_update_submitted>
  <last_update_submitted_qc>December 5, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">December 21, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>machine learning</keyword>
  <keyword>unruptured aneurysm</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Intracranial Aneurysm</mesh_term>
    <mesh_term>Aneurysm</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>February 26, 2021</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/74/NCT04819074/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

